HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Korea’s Ssangyong Engineering & Construction and Daewoo Engineering & Construction, together with Catalist-listed Koh Brothers Eco Engineering have been awarded the W788 billion (US$735.8 million) Woodlands Health Campus (WHC) development project in Singapore by the ministry of health.
Australian dental care chain 1300 Smiles is to acquire a dental practice in Buderim, Queensland. The practice provides a full range of dental services including cosmetic and orthodontic to the Sunshine Coast community.
Sydney-headquartered wireless urinary incontinence technology company Simavita has secured commitments to raise A$1.4 million (US$1.1 million) by way of unsecured convertible notes.
IVD and medical imaging company Yestar Healthcare has appointed Chan Chung Man as chief operating officer. Chan is responsible for the business development, marketing and management of the medical consumable business of the group. With his experience in merger and acquisitions, he has also assisted the group with a number of m&as in recent years.
Top Glove Corporation has signed a US$310 million unsecured syndicated loan with a consortium of eight banks. It is the largest syndicated credit facility closed by the group and proceeds will be used for its M$1.4 billion (US$345 million) acquisition of Adventa Capital-owned Aspion.
China Isotope & Radiation, which manufactures diagnostic and therapeutic radiopharmaceuticals products, has refiled plans for an up to US$200 million IPO on the Hong Kong Stock Exchange. Sole sponsor remains CICC.
Despite what is traditionally a soft quarter, Top Glove Corporation, the world’s largest rubber glove manufacturer, has reported a 32.2% rise in second quarter profits to M$110 million (US$28.2 million) on revenues that rose 12.6% to M$958.4 million.
Eureka Group Holdings, a property asset manager of senior independent living communities across Australia, is to acquire five seniors rental villages in Tasmania from Ingenia for A$18 million (US$14.2 million).
IVD and medical imaging company Yestar Healthcare has reported an almost 30% rise in profits for the year. They were up 29.9% to Rmb350.6 million (US$55.5 million) on revenues that were also up 30% to Rmb3.9 billion.
Kam Yuen, chairman and CEO of Hang Seng-listed Golden Meditech, has increased his shareholding in the group. He acquired just over 9 million shares for around HK$8.5 million (US$1.1 million).

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




Markets in Asia were mixed today, though all eyes were on the Nikkei. It fell as much as 1.3% this morning as the country struggles with a political scandal. “We will continue to follow the developments as the country continues to grapple with the land sale scandal implicating finance minister Aso, prime minister Abe and his wife,” said UOB in a note to clients this morning. More broadly, risk appetite in the region was off as investors await the Federal Open Market Committee’s latest policy statement and its economic outlook for the US on Wednesday. The market has already priced in a 25bp interest rate rise from incoming chairman Jerome Powell, but key will be any indication he gives about the number of future hikes this year. “The slowdown in February’s inflation growth has so far tamed some expectations, though any hawkish surprise may still send a shockwave through markets,” said Jingyi Pan, market analyst for IG, in Singapore.



HealthInvestor Asia twitter feed


HealthInvestor UK